I DISAGREE 100% (yelling intended). The Primar
Post# of 148300
(Total Views: 694)
Posted On: 08/01/2020 1:57:07 PM
Re: craigakess #46566
I DISAGREE 100% (yelling intended).
The Primary endpoint for Renegeron's REGN10933+REGN10987 trials is SAEs.
(https://clinicaltrials.gov/ct2/show/NCT04426695?term=regeneron+covid&draw=2&rank=3
If you/your wife/husband/child/brother/sister were mildly sick with covid, which is more important?
Persistence of cough at 14 days
or
Serious Adverse Events
I'll deal with the cough
The 64% reduction in SAEs is by itself a result. I have no more money to buy any more stock, but I would if I could.
As one investing blogger wrote (wish I remembered where), after these SAE results we know that Leronlimab won the game, we just don't know the score.
The Primary endpoint for Renegeron's REGN10933+REGN10987 trials is SAEs.
(https://clinicaltrials.gov/ct2/show/NCT04426695?term=regeneron+covid&draw=2&rank=3
If you/your wife/husband/child/brother/sister were mildly sick with covid, which is more important?
Persistence of cough at 14 days
or
Serious Adverse Events
I'll deal with the cough
The 64% reduction in SAEs is by itself a result. I have no more money to buy any more stock, but I would if I could.
As one investing blogger wrote (wish I remembered where), after these SAE results we know that Leronlimab won the game, we just don't know the score.
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼